Literature DB >> 6789853

Initiation and promotion at different ages and doses in 2200 mice. I. Methods, and the apparent persistence of initiated cells.

F Stenbäck, R Peto, P Shubik.   

Abstract

Delay between initiation and promotion on mouse skin was in 1949 reported by Berenblum and Shubik not to affect tumour yields, and this led to the important concept of the irreversibility of initiation and stimulated the development of multistage models. Subsequent reports have, however, suggested that delay does decrease tumour yields, and this is confirmed by the present study of 2200 mice initiated at 8, 48, or 68 weeks with 10, 30, 100, or 300 microgram of DMBA and promoted by a standard dose of TPA for 15 weeks, after various delays. However, our data suggest that the decrease in tumour yields is chiefly or wholly due to a reduction, among ageing mice, of the ability to respond to promoters, and not to any substantial loss of initiated cells, for late initiation with immediate promotion also yielded a less rapid response than early initiation with immediate promotion. Interpretation of all such studies is complicated by the few weeks that the skin needs to repair ulceration and other damage induced by the higher doses of DMBA, for if promotion with TPA begins before such repair is complete the tumour yield may be misleadingly increased.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6789853      PMCID: PMC2010659          DOI: 10.1038/bjc.1981.141

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  16 in total

1.  Conservatism of the approximation sigma (O-E)2-E in the logrank test for survival data or tumor incidence data.

Authors:  R Peto; M C Pike
Journal:  Biometrics       Date:  1973-09       Impact factor: 2.571

2.  Effect of aging in two-stage carcinogenesis on mouse skin with phorbol myristate acetate as promoting agent.

Authors:  B L Van Duuren; A C Smith; S M Melchionne
Journal:  Cancer Res       Date:  1978-03       Impact factor: 12.701

3.  The effect of aging and interval between primary and secondary treatment in two-stage carcinogenesis on mouse skin.

Authors:  B L Van Duuren; A Sivak; C Katz; I Seidman; S Melchionne
Journal:  Cancer Res       Date:  1975-03       Impact factor: 12.701

4.  On the persistence of tumour initiation and the acceleration of tumour progression in mouse skin tumorigenesis.

Authors:  F J Roe; R L Carter; B C Mitchley; R Peto; E Hecker
Journal:  Int J Cancer       Date:  1972-03-15       Impact factor: 7.396

5.  The tumor-promoting activity of tobacco leaf extract and whole cigarette tar.

Authors:  B L Van Duuren; A Sivak; L Langseth
Journal:  Br J Cancer       Date:  1967-06       Impact factor: 7.640

6.  Studies in carcinogenesis.

Authors:  I Hieger
Journal:  Br J Cancer       Date:  1965-12       Impact factor: 7.640

7.  Significant variation in mouse-skin aryl hydrocarbon hydroxylase inducibility as a function of the hair growth cycle.

Authors:  L Manil; J Van Cantfort; C M Lapière; J E Gielen
Journal:  Br J Cancer       Date:  1981-02       Impact factor: 7.640

8.  An experimental analysis of the hair cycle effect in mouse skin carcinogenesis.

Authors:  I BERENBLUM; N HARAN-GHERA; N TRAININ
Journal:  Br J Cancer       Date:  1958-09       Impact factor: 7.640

9.  The persistence of latent tumour cells induced in the mouse's skin by a single application of 9:10-dimethyl-1:2-benzanthracene.

Authors:  I BERENBLUM; P SHUBIK
Journal:  Br J Cancer       Date:  1949-09       Impact factor: 7.640

10.  Initiation and promotion at different ages and doses in 2200 mice. III. Linear extrapolation from high doses may underestimate low-dose tumour risks.

Authors:  F Stenbäck; R Peto; P Shubik
Journal:  Br J Cancer       Date:  1981-07       Impact factor: 7.640

View more
  13 in total

1.  Cell of origin and microenvironment contribution for NF1-associated dermal neurofibromas.

Authors:  Lu Q Le; Tracey Shipman; Dennis K Burns; Luis F Parada
Journal:  Cell Stem Cell       Date:  2009-05-08       Impact factor: 24.633

2.  Loss of integrin α3 prevents skin tumor formation by promoting epidermal turnover and depletion of slow-cycling cells.

Authors:  Norman Sachs; Pablo Secades; Laura van Hulst; Maaike Kreft; Ji-Ying Song; Arnoud Sonnenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-10       Impact factor: 11.205

Review 3.  Histone modifications: Targeting head and neck cancer stem cells.

Authors:  John M Le; Cristiane H Squarize; Rogerio M Castilho
Journal:  World J Stem Cells       Date:  2014-11-26       Impact factor: 5.326

4.  High constant incidence rates of second primary cancers of the head and neck: a pooled analysis of 13 cancer registries.

Authors:  Cristina Bosetti; Ghislaine Scelo; Shu-Chun Chuang; Jon M Tonita; Sharon Tamaro; Jon G Jonasson; Erich V Kliewer; Kari Hemminki; Elisabete Weiderpass; Eero Pukkala; Elizabeth Tracey; Jorgen H Olsen; Vera Pompe-Kirn; David H Brewster; Carmen Martos; Kee-Seng Chia; Paul Brennan; Mia Hashibe; Fabio Levi; Carlo La Vecchia; Paolo Boffetta
Journal:  Int J Cancer       Date:  2010-11-09       Impact factor: 7.396

Review 5.  Transgenic mice and squamous multistage skin carcinogenesis.

Authors:  K Brown; A Balmain
Journal:  Cancer Metastasis Rev       Date:  1995-06       Impact factor: 9.264

6.  Statistical properties of a two-stage model of carcinogenesis.

Authors:  C J Portier
Journal:  Environ Health Perspect       Date:  1987-12       Impact factor: 9.031

7.  Initiation and promotion at different ages and doses in 2200 mice. II. Decrease in promotion by TPA with ageing.

Authors:  F Stenbäck; R Peto; P Shubik
Journal:  Br J Cancer       Date:  1981-07       Impact factor: 7.640

Review 8.  The critical roles of somatic mutations and environmental tumor-promoting agents in cancer risk.

Authors:  Allan Balmain
Journal:  Nat Genet       Date:  2020-10-26       Impact factor: 38.330

Review 9.  Multistage models of carcinogenesis.

Authors:  P Armitage
Journal:  Environ Health Perspect       Date:  1985-11       Impact factor: 9.031

10.  Initiation and promotion at different ages and doses in 2200 mice. III. Linear extrapolation from high doses may underestimate low-dose tumour risks.

Authors:  F Stenbäck; R Peto; P Shubik
Journal:  Br J Cancer       Date:  1981-07       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.